In previous studies, it has been demonstrated that some of that specific MRI features [enhancement quality (F4), tumor-enhancing proportion (F5), tumor–non-enhancing proportion (F6), and necrosis proportion (F7)] can be used to predict the grade and IDH status of gliomas, with important prognostic implications. The gene discussed is IDH1; the disease is neoplasm.